- 期刊
Factors Associated with Utilization of Dipeptidyl-4 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Retrospective Study
延伸閱讀
- Lin, Y. H. (2021). Predictors of the Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Taiwanese Patients with Type 2 Diabetes Mellitus [master's thesis, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU202100421
- Zhang, X., Brooks, B., Molyneaux, L., Landy, E., Banatwalla, R., Wu, T., Wong, J., Su, B., & Yue, D. K. (2014). Dipeptidyl Peptidase-4 Inhibitors as a Third-Line Oral Antihyperglycaemic Agent in Patients with Type 2 Diabetes Mellitus: The Impact of Ethnicity. International Journal of Endocrinology, 2014(), 620-624-066. https://doi.org/10.1155/2014/354040
- Lin, C. L. (2014). Association between Serum Trace Elements and Renal Toxicology in Elderly Patients with type 2 diabetes mellitus: A Cross-Sectional Study [master's thesis, Kaohsiung Medical University]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0011-3007201411495900
- 柳素燕（2012）。A Study of Adherence and Factors Related of Insulin Injection in Patients with Type 2 Diabetes Mellitus〔碩士論文，高雄醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0011-2507201222153700
- Hirao, K., Maeda, H., Shirabe, S. I., Yamamoto, R., Hirao, T., Hirao, S., Yamauchi, M., & Arai, K. (2012). Combination Therapy with a Dipeptidyl Peptidase-4 Inhibitor, Sulfonylurea, and Metformin Markedly Improves HbA_(1c) Levels in Japanese Patients with Type 2 Diabetes Mellitus. Japanese Clinical Medicine, (), 1-7. https://doi.org/10.4137/JCM.S8571